Disomotide
Cat.No:CLP0091 Solarbio
CAS:181477-43-0
Molecular Formula:C47H74N10O14S1
Molecular Weight:1035.22
Purity:≥95%
Appearance:Lyophilized powder
Storage:Store at -20℃,2 years.(Avoid freeze/thaw cycles)
Qty:
Size:
{{cart_num}}
My CartCAS:181477-43-0
Molecular Formula:C47H74N10O14S1
Molecular Weight:1035.22
Purity:≥95%
Appearance:Lyophilized powder
Storage:Store at -20℃,2 years.(Avoid freeze/thaw cycles)
Qty:
Size:
Product Type | Peptides |
CAS | 181477-43-0 |
Sequence(1LC) | IMDQVPFSV |
Sequence(3LC) | Ile-Met-Asp-Gln-Val-Pro-Phe-Ser-Val |
Molecular Formula | C47H74N10O14S1 |
Molecular Weight | 1035.22 |
Purity | ≥95% |
Appearance | Lyophilized powder |
Salt Form | Trifluoroacetate salt |
Source | Synthetic |
Storage | Store at -20℃,2 years.(Avoid freeze/thaw cycles) |
Category/Label | Cancer Research |
Background | Modified sequence of the gp100 epitope gp(209-217) ITDQVPFSV, in which a methionine replaced the natural threonine at position 2, bound to the HLA-A2 molecule with greater affinity than the unmodified peptide and was shown to have an increased ability to generate melanoma-reactive cytotoxic T lymphocytes (CTLs) in vitro when used for sensitization of peripheral blood mononuclear cells. IMDQVPFSV hold promise for the development of novel cancer immunotherapies. |
Reference | [1] Schaed, S. et al. Clin. Canc. Res. 8, 967 (2002); [2] Paczesny, S. et al. JEM 199, 1503 (2004). |
Unit | Bottle |
Specification | 1mg 5mg |
Remark:These protocols are for reference only. Solarbio does not independently validate these methods.
Note:
1. The products are all for scientific research use only. Do not use it for medical, clinical diagnosis or treatment, food and cosmetics, etc. Do not store them in ordinary residential areas.
2. For your safety and health, please wear laboratory clothes, disposable gloves and masks.
3. The experimental results may be affected by many factors, after-sale service is limited to the product itself and does not involve other compensation.
Sorry, there is no experimental images.
Sorry, there is no more information.
Sorry, there is no more information.